{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T20:03:54Z","timestamp":1790366634927,"version":"4.1.0"},"reference-count":33,"publisher":"Medknow","issue":"4","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,5,13]],"date-time":"2015-05-13T00:00:00Z","timestamp":1431475200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["saudiophthaljournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Saudi Journal of Ophthalmology"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.sjopt.2015.05.005","type":"journal-article","created":{"date-parts":[[2015,6,7]],"date-time":"2015-06-07T00:53:30Z","timestamp":1433638410000},"page":"287-291","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Platelet derived growth factor inhibitors: A potential therapeutic approach for ocular neovascularization"],"prefix":"10.4103","volume":"29","author":[{"given":"Mohammad Ali","family":"Sadiq","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa","family":"Hanout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salman","family":"Sarwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2030-2308","authenticated-orcid":false,"given":"Diana V.","family":"Do","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan Dong","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasir Jamal","family":"Sepah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2581","reference":[{"key":"10.1016\/j.sjopt.2015.05.005_b0005","unstructured":"Demoulin JB, Montano-Almendras CP. Platelet-derived growth factors and their receptors in normal and malignant hematopoiesis. Am J Blood Res 2012;2(1):44\u201356 [PubMed PMID: 22432087. Pubmed Central PMCID: PMC3301440. Epub 2012\/03\/21. Eng]."},{"key":"10.1016\/j.sjopt.2015.05.005_b0010","doi-asserted-by":"crossref","unstructured":"Andrae J, Gallini R, Betsholtz C. Role of platelet-derived growth factors in physiology and medicine. Genes Dev 2008;22(10):1276\u2013312 [PubMed PMID: 18483217. Pubmed Central PMCID: PMC2732412. Epub 2008\/05\/17. Eng].","DOI":"10.1101\/gad.1653708"},{"key":"10.1016\/j.sjopt.2015.05.005_b0015","doi-asserted-by":"crossref","unstructured":"Edqvist PH, Niklasson M, Vidal-Sanz M, Hallbook F, Forsberg-Nilsson K. Platelet-derived growth factor over-expression in retinal progenitors results in abnormal retinal vessel formation. PloS One 2012;7(8):e42488 [PubMed PMID: 22880002. Pubmed Central PMCID: PMC3411765. Epub 2012\/08\/11. Eng].","DOI":"10.1371\/journal.pone.0042488"},{"key":"10.1016\/j.sjopt.2015.05.005_b0020","doi-asserted-by":"crossref","unstructured":"Heldin CH, Westermark B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev 1999;79(4):1283\u2013316 [PubMed PMID: 10508235. Epub 1999\/10\/03. Eng].","DOI":"10.1152\/physrev.1999.79.4.1283"},{"key":"10.1016\/j.sjopt.2015.05.005_b0025","doi-asserted-by":"crossref","unstructured":"Alvarez RH, Kantarjian HM, Cortes JE. Biology of platelet-derived growth factor and its involvement in disease. Mayo Clin Proc 2006;81(9):1241\u201357 [PubMed PMID: 16970222. Epub 2006\/09\/15. Eng].","DOI":"10.4065\/81.9.1241"},{"key":"10.1016\/j.sjopt.2015.05.005_b0030","doi-asserted-by":"crossref","unstructured":"Fruttiger M, Calver AR, Richardson WD. Platelet-derived growth factor is constitutively secreted from neuronal cell bodies but not from axons. Curr Biol : CB 2000;10(20):1283\u20136 [PubMed PMID: 11069109. Epub 2000\/11\/09. Eng].","DOI":"10.1016\/S0960-9822(00)00757-0"},{"key":"10.1016\/j.sjopt.2015.05.005_b0035","unstructured":"Reneker LW, Overbeek PA. Lens-specific expression of PDGF-A in transgenic mice results in retinal astrocytic hamartomas. Invest Ophth Vis Sci 1996;37(12):2455\u201366 [PubMed PMID: 8933762. Epub 1996\/11\/01. Eng]."},{"key":"10.1016\/j.sjopt.2015.05.005_b0040","doi-asserted-by":"crossref","unstructured":"Tang Z, Arjunan P, Lee C, Li Y, Kumar A, Hou X, et al. Survival effect of PDGF-CC rescues neurons from apoptosis in both brain and retina by regulating GSK3beta phosphorylation. J Exp Med 2010;207(4):867\u201380 [PubMed PMID: 20231377. Pubmed Central PMCID: 2856029].","DOI":"10.1084\/jem.20091704"},{"key":"10.1016\/j.sjopt.2015.05.005_b0045","doi-asserted-by":"crossref","unstructured":"Wang Y, Abu-Asab MS, Yu CR, Tang Z, Shen D, Tuo J, et al. Platelet-derived growth factor (PDGF)-C inhibits neuroretinal apoptosis in a murine model of focal retinal degeneration. Lab Invest; A J Tech Method Pathol 2014;94(6):674\u201382 [PubMed PMID: 24709779. Pubmed Central PMCID: 4039574].","DOI":"10.1038\/labinvest.2014.60"},{"key":"10.1016\/j.sjopt.2015.05.005_b0050","doi-asserted-by":"crossref","unstructured":"Lindahl P, Johansson BR, Leveen P, Betsholtz C. Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science (New York, NY) 1997;277(5323):242\u20135 [PubMed PMID: 9211853. Epub 1997\/07\/11. Eng].","DOI":"10.1126\/science.277.5323.242"},{"key":"10.1016\/j.sjopt.2015.05.005_b0055","doi-asserted-by":"crossref","unstructured":"Mudhar HS, Pollock RA, Wang C, Stiles CD, Richardson WD. PDGF and its receptors in the developing rodent retina and optic nerve. Development (Cambridge, England) 1993;118(2):539\u201352 [PubMed PMID: 8223278. Epub 1993\/06\/01. Eng].","DOI":"10.1242\/dev.118.2.539"},{"key":"10.1016\/j.sjopt.2015.05.005_b0060","doi-asserted-by":"crossref","unstructured":"Trojanowska M. Role of PDGF in fibrotic diseases and systemic sclerosis. Rheumatology (Oxford, England) 2008;47 Suppl 5:v2\u20134 [PubMed PMID: 18784131. Epub 2008\/09\/17. Eng].","DOI":"10.1093\/rheumatology\/ken265"},{"key":"10.1016\/j.sjopt.2015.05.005_b0065","doi-asserted-by":"crossref","unstructured":"Grimminger F, Schermuly RT. PDGF receptor and its antagonists: role in treatment of PAH. Adv Exp Med Biol 2010;661:435\u201346 [PubMed PMID: 20204747. Epub 2010\/03\/06. Eng].","DOI":"10.1007\/978-1-60761-500-2_28"},{"key":"10.1016\/j.sjopt.2015.05.005_b0070","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1038\/ncomms3129","article-title":"Tumour PDGF-BB expression levels determine dual effects of anti-PDGF drugs on vascular remodelling and metastasis","volume":"4","author":"Hosaka","year":"2013","journal-title":"Nature Commun"},{"issue":"17","key":"10.1016\/j.sjopt.2015.05.005_b0075","doi-asserted-by":"crossref","first-page":"8715","DOI":"10.1158\/0008-5472.CAN-05-4665","article-title":"AMG 706, an oral, multikinase inhibitor that selectively targets vascular endothelial growth factor, platelet-derived growth factor, and kit receptors, potently inhibits angiogenesis and induces regression in tumor xenografts","volume":"66","author":"Polverino","year":"2006","journal-title":"Can Res"},{"key":"10.1016\/j.sjopt.2015.05.005_b0080","doi-asserted-by":"crossref","unstructured":"Crino L, Metro G. Therapeutic options targeting angiogenesis in nonsmall cell lung cancer. Eur Respir Rev: An Off J Eur Respir Soc 2014;23(131):79\u201391 [PubMed PMID: 24591665. Epub 2014\/03\/05. Eng].","DOI":"10.1183\/09059180.00008913"},{"key":"10.1016\/j.sjopt.2015.05.005_b0085","unstructured":"Michaelson I. The mode of development of the vascular system of the retina with some observations on its significance for certain retinal diseases. Trans Ophthalmol Soc UK 1948;68:137\u201380."},{"issue":"4","key":"10.1016\/j.sjopt.2015.05.005_b0090","first-page":"1119","article-title":"Platelet-derived growth factor indirectly stimulates angiogenesis in vitro","volume":"142","author":"Sato","year":"1993","journal-title":"Am J Pathol"},{"key":"10.1016\/j.sjopt.2015.05.005_b0095","doi-asserted-by":"crossref","unstructured":"Inaba T, Ishibashi S, Gotoda T, Kawamura M, Morino N, Nojima Y, et al. Enhanced expression of platelet-derived growth factor-beta receptor by high glucose involvement of platelet-derived growth factor in diabetic angiopathy. Diabetes 1996;45(4):507\u201312. [PubMed PMID: 8603774. Epub 1996\/04\/01. Eng].","DOI":"10.2337\/diab.45.4.507"},{"key":"10.1016\/j.sjopt.2015.05.005_b0100","doi-asserted-by":"crossref","unstructured":"Seo MS, Okamoto N, Vinores MA, Vinores SA, Hackett SF, Yamada H, et al. Photoreceptor-specific expression of platelet-derived growth factor-B results in traction retinal detachment. Am J Pathol 2000;157(3):995\u20131005 [PubMed PMID: 10980138. Pubmed Central PMCID: PMC1885694. Epub 2000\/09\/12. Eng].","DOI":"10.1016\/S0002-9440(10)64612-3"},{"key":"10.1016\/j.sjopt.2015.05.005_b0105","doi-asserted-by":"crossref","unstructured":"Koyama N, Watanabe S, Tezuka M, Morisaki N, Saito Y, Yoshida S. Migratory and proliferative effect of platelet-derived growth factor in rabbit retinal endothelial cells: evidence of an autocrine pathway of platelet-derived growth factor. J Cell Physiol 1994;158(1):1\u20136 [PubMed PMID: 7505273. Epub 1994\/01\/01. Eng].","DOI":"10.1002\/jcp.1041580102"},{"key":"10.1016\/j.sjopt.2015.05.005_b0110","doi-asserted-by":"crossref","unstructured":"Freyberger H, Brocker M, Yakut H, Hammer J, Effert R, Schifferdecker E, et al. Increased levels of platelet-derived growth factor in vitreous fluid of patients with proliferative diabetic retinopathy. Exp Clin Endocrinol Diabet: Off J, German Soc Endocrinolo [and] German Diabetes Assoc 2000;108(2):106\u20139 [PubMed PMID: 10826517. Epub 2000\/05\/29. Eng].","DOI":"10.1055\/s-2000-5803"},{"key":"10.1016\/j.sjopt.2015.05.005_b0115","unstructured":"Robbins SG, Mixon RN, Wilson DJ, Hart CE, Robertson JE, Westra I, et al. Platelet-derived growth factor ligands and receptors immunolocalized in proliferative retinal diseases. Invest Ophthalmol Visual Sci 1994;35(10):3649\u201363 [PubMed PMID: 8088954. Epub 1994\/09\/01. Eng]."},{"key":"10.1016\/j.sjopt.2015.05.005_b0120","doi-asserted-by":"crossref","unstructured":"Dong A, Seidel C, Snell D, Ekawardhani S, Ahlskog JK, Baumann M, et al. Antagonism of PDGF-BB suppresses subretinal neovascularization and enhances the effects of blocking VEGF-A. Angiogenesis 2013 [PubMed PMID: 24154861. Epub 2013\/10\/25]. Eng].","DOI":"10.1007\/s10456-013-9402-5"},{"key":"10.1016\/j.sjopt.2015.05.005_b0125","unstructured":"Ophthotech C. A Phase 1, Safety, Tolerability and Pharmacokinetic Profile of Intravitreous Injections of E10030 (Anti-PDGF Pegylated Aptamer) in Subjects With Neovascular Age-Related Macular Degeneration. US National Institutes of Health. 2007 [2013 December 12] <http:\/\/clinicaltrials.gov\/show\/NCT00569140>."},{"key":"10.1016\/j.sjopt.2015.05.005_b0130","unstructured":"Jordi Mones M, Barcelona, Spain. Inhibiting VEGF and PDGF to Treat AMD REVIEW of Ophthalmology2011 http:\/\/www.revophth.com\/content\/d\/retinal_insider\/c\/29979\/."},{"key":"10.1016\/j.sjopt.2015.05.005_b0135","unstructured":"Ophthotech C. A Safety and Efficacy Study of E10030 (Anti-PDGF Pegylated Aptamer) Plus Lucentis for Neovascular Age-Related Macular Degeneration. US National Institutes of Health. 2010 [2013 December 12] <http:\/\/clinicaltrials.gov\/ct2\/show\/NCT01089517?term=NCT&rank=1>."},{"key":"10.1016\/j.sjopt.2015.05.005_b0140","unstructured":"Dugel, PU. Anti-PDGF combination therapy in neovascular age-related macular degeneration: results of a phase 2b study. RETINA TODAY. March, 2013 <http:\/\/retinatoday.com\/2013\/03\/anti-pdgf-combination-therapy-in-neovascular-age-related-macular-degeneration-results-of-a-phase-2b-study\/>."},{"key":"10.1016\/j.sjopt.2015.05.005_b0145","unstructured":"A Phase 3 Safety and Efficacy Study of Fovista\u2122 (E10030) Intravitreous Administration in Combination With Lucentis\u00ae Compared to Lucentis\u00ae Monotherapy 2013 <http:\/\/clinicaltrials.gov\/ct2\/show\/record\/NCT01940900?term=NCT01940900&rank=1>."},{"key":"10.1016\/j.sjopt.2015.05.005_b0150","unstructured":"A Phase 3 Safety and Efficacy Study of Fovista\u2122 (E10030) Intravitreous Administration in Combination With Either Avastin\u00ae or Eylea\u00ae Compared to Avastin\u00ae or Eylea\u00ae Monotherapy; 2013."},{"key":"10.1016\/j.sjopt.2015.05.005_b0155","doi-asserted-by":"crossref","unstructured":"Martin DF, Maguire MG, Fine SL, Ying GS, Jaffe GJ, Grunwald JE, et al. Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results. Ophthalmology 2012;119(7):1388\u201398 [PubMed PMID: 22555112. Pubmed Central PMCID: PMC3389193. Epub 2012\/05\/05. eng].","DOI":"10.1016\/j.ophtha.2012.03.053"},{"key":"10.1016\/j.sjopt.2015.05.005_b0160","unstructured":"Dugel PU. Anti-PDGF combination therapy in neovascular age-related macular degeneration: results of a phase 2b study 2013; (March)."},{"key":"10.1016\/j.sjopt.2015.05.005_b0165","doi-asserted-by":"crossref","unstructured":"Betsholtz C. Insight into the physiological functions of PDGF through genetic studies in mice. Cytok Growth Factor Rev 2004;15(4):215\u201328 [PubMed PMID: 15207813. Epub 2004\/06\/23. Eng].","DOI":"10.1016\/j.cytogfr.2004.03.005"}],"container-title":["Saudi Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319453415000594?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319453415000594?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T19:14:43Z","timestamp":1652296483000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1319453415000594"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S1319453415000594"],"URL":"https:\/\/doi.org\/10.1016\/j.sjopt.2015.05.005","relation":{},"ISSN":["1319-4534"],"issn-type":[{"value":"1319-4534","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Platelet derived growth factor inhibitors: A potential therapeutic approach for ocular neovascularization","name":"articletitle","label":"Article Title"},{"value":"Saudi Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sjopt.2015.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}